Journal Mobile Options
Table of Contents
Vol. 95, No. 3-4, 2001
Issue release date: 2001
Cytogenet Cell Genet 95:196–201 (2001)

The mouse Arhgef6 gene: cDNA sequence, expression analysis, and chromosome assignment

Kutsche K. · Gal A.
Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg (Germany)

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, have been shown to cause X-chromosomal non-specific mental retardation (MRX) in human. Here we report the identification and characterization of the orthologous mouse gene, Arhgef6. The gene transcript of approximately 4.4 kb is present in various mouse tissues indicating ubiquitous expression as found for human ARHGEF6. The open reading frame encodes a polypeptide of 771 amino acids with high homology to human ARHGEF6. The structural motifs of both proteins are conserved including an N-terminal CH domain, followed by an SH3 domain, and a tandem organization of the DH and PH domains. Analysis of the temporal expression pattern revealed that Arhgef6 is strongly expressed in the very early embryo and somewhat less in later stages. A genomic cosmid clone containing Arhgef6 exons 1 and 2 has been isolated and used for mapping the gene on the mouse X chromosome.   

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, Mulley JC, Walsh CA: PAK3 mutation in nonsyndromic X-linked mental retardation. Nature Genet 20:25–30 (1998).
  2. Billuart P, Bienvenu T, Ronce N, des Portes V, Vinet MC, Zemni R, Roest Crollius H, Carrie A, Fauchereau F, Cherry M, Briault S, Hamel B, Fryns JP, Beldjord C, Kahn A, Moraine C, Chelly J: Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 392:923–926 (1998).
  3. Boyd Y, Blair HJ, Cunliffe P, Denny P, Gormally E, Herman GE: Encyclopedia of the mouse genome VII. Mouse chromosome X. Mammal Genome 8 Spec No:S361–S377 (1998).
  4. Boyd Y, Blair HJ, Cunliffe P, Masson WK, Reed V: A phenotype map of the mouse X chromosome: models for human X-linked disease. Genome Res 10:277–292 (2000).
  5. Boyd Y, Denny P, Masson W, Reed V, Elliott R: Mouse X chromosome. Mammal Genome 10:961 (1999).
  6. Bustello XR: Regulatory and signaling properties of the Vav family. Mol Cell Biol 20:1461–1477 (2000).
  7. Cerione RA, Zheng Y: The Dbl family of oncogenes. Curr Biol 8:216–222 (1996).
  8. Dickson BJ: Rho GTPases in growth cone guidance. Curr Opin Neurobiol 11:103–110 (2001).
  9. Djabali M, Mattei MG, Nguyen C, Roux D, Demengeot J, Denizot F, Moos M, Schachner M, Goridis C, Jordan BR: The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics 7:587–593 (1990).
  10. Hall A: Rho GTPases and the actin cytoskeleton. Science 279:509–514 (1998).
  11. Hoshino M, Sone M, Fukata M, Kuroda S, Kaibuchi K, Nabeshima Y, Hama C: Identification of the stef gene that encodes a novel guanine nucleotide exchange factor specific for Rac1. J biol Chem 274:17837–17844 (1999).
  12. Kozak M: At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J molec Biol 196:947–950 (1987).
  13. Kutsche K, Yntema H, Brandt A, Jantke I, Nothwang HG, Orth U, Boavida MG, David D, Chelly J, Fryns JP, Moraine C, Ropers HH, Hamel BC, van Bokhoven H, Gal A: Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nature Genet 26:247–250 (2000).
  14. Liu G, Lu W, Bremer S, Hameister H, Schreiner B, Hughes M, Heng HH: Spectral karyotyping of mouse cell line WMP2. Cytogenet Cell Genet 90:271–274 (2000).
  15. Luo L: Rho GTPases in neuronal morphogenesis. Nature Rev Neurosci 1:173–180 (2000).

    External Resources

  16. Manser E, Loo T-H, Koh C-G, Zhao Z-S, Chen X-Q, Tan L, Tan I, Leung T, Lim L: PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1:183–192 (1998).

    External Resources

  17. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, Sato S, Nagase T, Seki N, Ishikawa K, Tabata S: Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001–KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement). DNA Res 1:47–56 (1994).
  18. O’Brien SP, Seipel K, Medley QG, Bronson R, Segal R, Streuli M: Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. Proc natl Acad Sci, USA 97:12074–12078 (2000).
  19. Ohno S: Ancient linkage groups and frozen accidents. Nature 244:259–262 (1973).
  20. Pasteris NG, Gorski JL: Isolation, characterization, and mapping of the mouse and human Fgd2 genes, faciogenital dysplasia (FGD1; Aarskog syndrome) gene homologues. Genomics 60:57–66 (1999).

    External Resources

  21. Pasteris NG, Nagata K, Hall A, Gorski JL: Isolation, characterization, and mapping of the mouse Fgd3 gene, a new faciogenital dysplasia (FGD1; Aarskog Syndrome) gene homologue. Gene 242:237–247 (2000).

    External Resources

  22. Van Aelst, D’Souza-Schorey: Rho GTPases and signaling networks. Genes Dev 11:2295–2322 (1997).
  23. Whitehead IP, Campbell S, Rossman KL, Der CJ: Dbl family proteins. Biochim biophys Acta 1332:F1–F23 (1997).

    External Resources

  24. Yoshii S, Tanaka M, Otsuki Y, Wang DY, Guo RJ, Zhu Y, Takeda R, Hanai H, Kaneko E, Sugimura H: alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene 18:5680–90 (1999).

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50